Plasma level of soluble uPAR (suPAR) alone and in combination with other biomarkers serves as a prognostic predictor and a marker in patients with sepsis and systemic inflammatory response (SIRS) (16, 17). The gene discussed is PLAUR; the disease is Sepsis.